Hilla Ben-Pazi: AMIT301 Receives Approval in Israel for Continuous Stroke Monitoring
Hilla Ben-Pazi, Founder and CEO of Avertto Medical LTD, shared on LinkedIn:
”We are excited to share that Avertto has received approval to begin selling AMIT301 in the Israeli market — an important milestone for our company and for the future of continuous stroke monitoring.
AMIT301 is named in memory of the brave paramedic Amit Man, whose dedication to saving lives continues to inspire us every day.
Her legacy lives on through our mission: developing technologies to detect critical cerebrovascular changes earlier and improve patient outcomes.
For those less familiar with the Israeli regulatory pathway, this milestone signifies successful local registration and paves the way for early clinical adoption in Israel.
We are also looking forward to working with our early Israeli adopters, Shady Jahshan, Hillit Cohen, and David Orion, and learning from their feedback as we continue to improve and expand the platform.
It is also a reminder of the strength of the Israeli innovation ecosystem — where medicine, engineering, clinical collaboration, and entrepreneurship come together to transform bold ideas into life-saving technologies.
A huge thank you to our incredible team, Asher Kuper, Kety Bardugo, Yair Lavi, Meron Ben Pazi, and Lior Elmaliach, for the dedication, persistence, and hard work that made this possible.
This achievement belongs to all of you.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization